Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.

[1]  C. Ledent,et al.  Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Hong Zhang,et al.  Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis , 2009, Inflammatory bowel diseases.

[3]  E. Brouillet,et al.  Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease , 2009, Glia.

[4]  M. Camilleri,et al.  Cannabinoids in intestinal inflammation and cancer. , 2009, Pharmacological research.

[5]  M. Bifulco,et al.  Endocannabinoid system modulation in cancer biology and therapy. , 2009, Pharmacological research.

[6]  Cheol-Whan Lee,et al.  CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages. , 2009, Cardiovascular research.

[7]  J. Jallo,et al.  CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury. , 2009, Microvascular research.

[8]  C. Szabó,et al.  Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. , 2009, American journal of physiology. Heart and circulatory physiology.

[9]  F. Mach,et al.  CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion. , 2009, Journal of molecular and cellular cardiology.

[10]  J. Beckman.  Understanding peroxynitrite biochemistry and its potential for treating human diseases. , 2009, Archives of biochemistry and biophysics.

[11]  H. Pan,et al.  Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity. , 2009, American journal of physiology. Renal physiology.

[12]  R. Pertwee,et al.  Emerging strategies for exploiting cannabinoid receptor agonists as medicines , 2009, British journal of pharmacology.

[13]  H. Pan,et al.  Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death , 2008, Journal of Pharmacology and Experimental Therapeutics.

[14]  T. Veenstra,et al.  Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. , 2008, Gastroenterology.

[15]  V. Marzo,et al.  Targeting the endocannabinoid system: to enhance or reduce? , 2008, Nature Reviews Drug Discovery.

[16]  P. Pacher,et al.  Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[17]  J. Pedraza-Chaverri,et al.  Selective iNOS inhibition reduces renal damage induced by cisplatin. , 2008, Toxicology letters.

[18]  J. Romero,et al.  Cannabinoid CB2 receptors in human brain inflammation , 2008, British journal of pharmacology.

[19]  P. Pacher,et al.  Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioning , 2008, British journal of pharmacology.

[20]  Pál Pacher,et al.  Pivotal Advance: Cannabinoid‐2 receptor agonist HU‐308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis , 2007 .

[21]  K. Mackie,et al.  CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. , 2007, American journal of physiology. Heart and circulatory physiology.

[22]  L. Liaudet,et al.  Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity. , 2007, Journal of the American College of Cardiology.

[23]  Csaba Szabó,et al.  Peroxynitrite: biochemistry, pathophysiology and development of therapeutics , 2007, Nature Reviews Drug Discovery.

[24]  B. Cravatt,et al.  Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase. , 2007, American journal of physiology. Heart and circulatory physiology.

[25]  C. Edelstein,et al.  Cisplatin-Induced Acute Renal Failure Is Associated with an Increase in the Cytokines Interleukin (IL)-1β, IL-18, IL-6, and Neutrophil Infiltration in the Kidney , 2007, Journal of Pharmacology and Experimental Therapeutics.

[26]  G. Ramesh,et al.  Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. , 2007, Kidney international.

[27]  H. Pan,et al.  Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  H. Friess,et al.  Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis. , 2007, Gastroenterology.

[29]  C. Ledent,et al.  Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells , 2007, Nature Medicine.

[30]  P. Pacher,et al.  The Endocannabinoid System as an Emerging Target of Pharmacotherapy , 2006, Pharmacological Reviews.

[31]  F. Mach,et al.  Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice , 2005, Nature.

[32]  J. Pedraza-Chaverri,et al.  Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats , 2004, BMC pharmacology.

[33]  M. Guzmán,et al.  Cannabinoids: potential anticancer agents , 2003, Nature Reviews Cancer.

[34]  J. Groves,et al.  Potent Metalloporphyrin Peroxynitrite Decomposition Catalyst Protects Against the Development of Doxorubicin-Induced Cardiac Dysfunction , 2003, Circulation.

[35]  R. Schrier.  Cancer therapy and renal injury. , 2002, The Journal of clinical investigation.

[36]  G. Ramesh,et al.  TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity , 2002 .

[37]  M. Herkenham,et al.  International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.

[38]  J. Yamate,et al.  Participation of Different Macrophage Populations and Myofibroblastic Cells in Chronically Developed Renal Interstitial Fibrosis after Cisplatin-induced Renal Injury in Rats , 2002, Veterinary pathology.

[39]  Z. Berente,et al.  BGP-15 - a novel poly(ADP-ribose) polymerase inhibitor - protects against nephrotoxicity of cisplatin without compromising its antitumor activity. , 2002, Biochemical pharmacology.

[40]  H. Nick,et al.  Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. , 2001, Journal of the American Society of Nephrology : JASN.

[41]  P. Várnai,et al.  Identification of renox, an NAD(P)H oxidase in kidney. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Mechoulam,et al.  HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Hishida,et al.  The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. , 1998, The Journal of laboratory and clinical medicine.

[44]  J S Beckman,et al.  Peroxynitrite formation from macrophage-derived nitric oxide. , 1992, Archives of biochemistry and biophysics.

[45]  B. Freeman,et al.  Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. , 1991, Archives of biochemistry and biophysics.

[46]  F. Ries,et al.  Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  I. Fridovich,et al.  The biology and pathology of oxygen radicals. , 1978, Annals of internal medicine.

[48]  L. Liaudet,et al.  Nitric oxide and peroxynitrite in health and disease. , 2007, Physiological reviews.

[49]  G. Ramesh,et al.  TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. , 2002, The Journal of clinical investigation.

[50]  L. Liaudet,et al.  Serveur Académique Lausannois SERVAL serval.unil.ch , 2022 .

[51]  Serveur Académique Lausannois SERVAL serval.unil.ch , 2022 .